Please login to the form below
Ranbaxy wins FDA approval for Metformin in US
India-based Ranbaxy Laboratories' 100 per cent-owned Ohm Laboratories has won FDA approval to manufacture and market Metformin tablets in the US.
India-based Ranbaxy Laboratories' 100 per cent-owned Ohm Laboratories has won FDA approval to manufacture and market Metformin tablets in the US.
Ipca Laboratories, which has a strategic alliance with Ranbaxy, will manufacture the formulation at its facilities in India. Ranbaxy will commercialise the product in the US market, Ipca revealed in a press statement to the Bombay Stock Exchange.
Total annual US sales for Metformin, an insulin sensitising agent, was USD 379m, according to Ranbaxy.
Share
Related Hub content
Featured jobs
-
Account Director, Medical Education
-
Salary TBC
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
-
Senior Medical Writer
-
Competitive salary plus benefits
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
-
Events Executive
-
DOE
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Senior Medical Writer
-
Salary TBC
-
Senior Copywriter
-
Salary TBC
Subscribe to our email news alerts
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- GSK forms cell therapy R&D pact with star-studded biotech
- J&J bags FDA breakthrough designation for prostate cancer drug
- Merck seeks partner for disease-modifying osteoarthritis drug
- UCB gets bigger in rare diseases with $2.1bn purchase of Ra Pharma
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- The era of digital wellbeing
- Increased discount leads NICE to reverse positon on Clovis cancer drug
- Looking after the mental health of the Porterhouse family
- Bayer opens AI-enabled drug discovery center in UK
- In a U-turn, ICER takes more positive view of AbbVie’s Rinvoq
- Roche’s MabThera beats incumbent drug in pemphigus vulgaris phase 3
PMHub
Novasecta
We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...
Latest intelligence
- The era of digital wellbeing
- Social media - friend or foe?...
- World Mental Health Day 2019: Employment and Mental Illness
- Mednet Group's white paper with a focus on navigating the world of work is available online in aid of World Mental Health Day 2019....
- Changing direction: adapting to a rapidly-evolving environment
- Chris Ross examines why creative partnerships could be key to commercial success in today’s healthcare marketplace...
Quick links
Infographics
